Global New-Born Screening Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global New-Born Screening Market Research Report 2024
Most of the infants are born normal and healthy at the time of birth and with no family history of disorders . Unfortunately, once symptom appears in child, they are often irreversible leading to severe health and developmental problems. Newborn screening helps in identifying diseases, which can affect a child’s health in the long run, at an early stage. Newborn screening, which includes a series of tests, is essential for early detection, diagnosis, and management , to prevent disability and death of a child. These tests, which are performed shortly after the birth of a baby, are used for the detection of genetic, developmental, and metabolic disorders in newborn babies.
According to MRAResearch’s new survey, global New-Born Screening market is projected to reach US$ 1357.7 million in 2033, increasing from US$ 790.6 million in 2022, with the CAGR of 7.6% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole New-Born Screening market research.
North America dominates the global market for newborn screening due to the need for reducing healthcare cost . Asia is expected to witness high growth rates in the next five years in the newborn screening market . China and India are expected to be the fastest-growing newborn screening markets in Asia Pacific. Some of the key growth drivers of the newborn screening market in emerging countries are the large pool of patients, increasing healthcare expenditure, and rising government funding and initiatives.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global New-Born Screening market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
GE Healthcare
Trivitron Healthcare
AB Sciex
Perkinelmer
Bio-Rad Laboratories
Agilent Technologies
Medtronic
Masimo
Waters
Natus Medical
Segment by Type
Tandem Mass Spectrometry
Pulse Oximetry Screening Technology
DNA-Based Assays
Hearing Screen Technology
Others
Hospitals
Clinics
Nursing Homes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The New-Born Screening report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global New-Born Screening market is projected to reach US$ 1357.7 million in 2033, increasing from US$ 790.6 million in 2022, with the CAGR of 7.6% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole New-Born Screening market research.
North America dominates the global market for newborn screening due to the need for reducing healthcare cost . Asia is expected to witness high growth rates in the next five years in the newborn screening market . China and India are expected to be the fastest-growing newborn screening markets in Asia Pacific. Some of the key growth drivers of the newborn screening market in emerging countries are the large pool of patients, increasing healthcare expenditure, and rising government funding and initiatives.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global New-Born Screening market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
GE Healthcare
Trivitron Healthcare
AB Sciex
Perkinelmer
Bio-Rad Laboratories
Agilent Technologies
Medtronic
Masimo
Waters
Natus Medical
Segment by Type
Tandem Mass Spectrometry
Pulse Oximetry Screening Technology
DNA-Based Assays
Hearing Screen Technology
Others
Segment by Application
Hospitals
Clinics
Nursing Homes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The New-Born Screening report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source